Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases
- PMID: 6169802
- DOI: 10.1007/BF00313295
Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases
Abstract
Cerebrospinal fluid (CSF) from 105 patients was analyzed by radioimmunoassay for the presence of material cross-reactive with peptide 89-169 of bovine myelin basic protein (BP). In a group of 72 multiple sclerosis patients, 52 showed higher BP content than the control group, i.e. more than 2 ng/ml CSF. Increased BP or BP fragments could be detected in CSF from almost all patients who recently (within 2 weeks) had had an acute episode, or after deterioration in the progressive form of the disease. Fifteen to 30 days after the onset of exacerbation or in a stable period, BP content decreases and in the slowly progressive form was in the range of the control group with one exception. BP content was also elevated in the CSF of patients with other neurological diseases. The presence of BP in the CSF from patients with isolated retrobulbar neuritis is of particular interest. Thus the presence of material cross-reactive with BP fragment 89-169 is not specific for multiple sclerosis, but is a useful parameter in diagnosis and evaluation of MS.
Similar articles
-
Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.Ann Neurol. 1980 Jan;7(1):58-64. doi: 10.1002/ana.410070111. Ann Neurol. 1980. PMID: 6153879
-
Myelin basic protein in the CSF of patients with multiple sclerosis, optic neuritis and various neurological diseases.Acta Neurol Belg. 1986 Nov-Dec;86(5):311-6. Acta Neurol Belg. 1986. PMID: 2433886
-
Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein.Proc Natl Acad Sci U S A. 1978 Apr;75(4):1976-8. doi: 10.1073/pnas.75.4.1976. Proc Natl Acad Sci U S A. 1978. PMID: 77020 Free PMC article.
-
Indicators of disease activity in multiple sclerosis. Studies of myelin basic protein-like materials.Ann N Y Acad Sci. 1984;436:140-50. doi: 10.1111/j.1749-6632.1984.tb14786.x. Ann N Y Acad Sci. 1984. PMID: 6085224 Review.
-
Myelin basic protein in cerebrospinal fluid and other body fluids.Mult Scler. 1998 Feb;4(1):16-21. doi: 10.1177/135245859800400105. Mult Scler. 1998. PMID: 9532587 Review.
Cited by
-
Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome and lymphocytic meningoradiculitis by isoelectric focusing.J Neurol. 1981;226(1):15-24. doi: 10.1007/BF00313314. J Neurol. 1981. PMID: 6181212
-
Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome.J Neurol. 1986 Jun;233(3):157-60. doi: 10.1007/BF00314423. J Neurol. 1986. PMID: 3522811
-
Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity.Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1110-1. doi: 10.1136/bmj.288.6424.1110. Br Med J (Clin Res Ed). 1984. PMID: 6201225 Free PMC article.
-
Cerebrospinal fluid markers in neurological disorders.Ital J Neurol Sci. 1990 Dec;11(6):537-47. doi: 10.1007/BF02337436. Ital J Neurol Sci. 1990. PMID: 1707039 Review.
-
Myelin basic protein in Fisher syndrome.J Neurol. 1985;232(4):263-4. doi: 10.1007/BF00313792. J Neurol. 1985. PMID: 2413179 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical